GB-0669
GB-0669-101
Phase 1 small_molecule completed
Quick answer
GB-0669 for SARS CoV-2 is a Phase 1 program (small_molecule) at Generate Biomedicines with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Generate Biomedicines
- Indication
- SARS CoV-2
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed